| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 0OJB0LES1A |
| InChI Key | CFKBNYUHQSQBSX-CYWCHRQTSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C22H25F3N4O3S |
| Molecular Weight | 482.53 |
| AlogP | 2.52 |
| Hydrogen Bond Acceptor | 6.0 |
| Hydrogen Bond Donor | 3.0 |
| Number of Rotational Bond | 6.0 |
| Polar Surface Area | 94.56 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 33.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| ANTAGONIST | C-C chemokine receptor type 2 antagonist | PubMed |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Ion channel
Voltage-gated ion channel
Potassium channels
Voltage-gated potassium channel
|
- | - | - | - | 21 | |
|
Membrane receptor
Family A G protein-coupled receptor
Peptide receptor (family A GPCR)
Chemokine receptor
CC chemokine receptor
|
- | 30-37 | - | 9600 | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Diabetes Mellitus, Type 2 | 2 | D003924 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 1228650-83-6 |
| ChEMBL | CHEMBL2204263 |
| DrugBank | DB12632 |
| FDA SRS | 0OJB0LES1A |
| PubChem | 46208367 |
| SureChEMBL | SCHEMBL2545786 |
| ZINC | ZINC000141611914 |